Director Lyn Baranowski will not stand for re-election at 2023 annual meeting

Rani Therapeutics Holdings, Inc.

Lyn Baranowski notified Rani Therapeutics she will not stand for re-election at the 2023 annual meeting.
She will cease to be a board member and member of Compensation and Nominating/Governance committees effective at the meeting.
Decision not due to any disagreement with the company on operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lyn Baranowski

Director

RANI · Rani Therapeutics Holdings, Inc.

Filed: April 5, 2023, 7:59 PM ET

On March 30, 2023, Ms. Lyn Baranowski notified Rani Therapeutics Holdings, Inc. (the “Company”) that she does not intend to stand for re-election at the 2023 annual meeting of stockholders of the Company (“Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lyn Baranowski departed as Director at Rani Therapeutics Holdings, Inc..

Action: does not intend to stand for re-election
Role: Director

Exact text from the filing

On March 30, 2023, Ms. Lyn Baranowski notified Rani Therapeutics Holdings, Inc. (the “Company”) that she does not intend to stand for re-election at the 2023 annual meeting of stockholders of the Company (“Annual Meeting”).

View on SEC.gov

Rani Therapeutics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-011909

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.